Differences in the personality profile of fibromyalgia patients and their relatives with and without fibromyalgia

Clinical and Experimental Rheumatology

Volumn 28, Issue 6 SUPPL. 63, 2010, Pages

  Glazer, Y ^a   Buskila, D ^a   Cohen, H ^b   Ebstein, R P ^c   Neumann, L ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MENTAL HEALTH CENTER   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Familial aggregation; Fibromyalgia; Personality traits

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; FIBROMYALGIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PERSONALITY; PRIORITY JOURNAL; QUESTIONNAIRE; RELATIVE; ANXIETY; COMPARATIVE STUDY; DEPRESSION; FAMILY; HEALTH SURVEY; INTERVIEW; ISRAEL; MIDDLE AGED; PERSONALITY TEST; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY;

ADULT; AGED; ANXIETY; DEPRESSION; FAMILY; FEMALE; FIBROMYALGIA; HEALTH SURVEYS; HUMANS; INTERVIEWS AS TOPIC; ISRAEL; MALE; MIDDLE AGED; PERSONALITY; PERSONALITY TESTS; RETROSPECTIVE STUDIES;

EID: 79952661209     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. CLONINGER CR, SVRAKIC DM, PRZYBECK TR: A psychobiological model of temperament and character. Arch Gen Psychiatry 1993; 50: 975-90.
2. HAWLEY DJ, WOLFE F, CATHEY MA: Pain, functional disability, and psychological status: a 12-month study of severity in fibromyalgia. J Rheumatol 1988; 15: 1551-6.
3. MAS AJ, CAARMONA L, VALVERDE M, RIBAS B; EPISER STUDY GROUP: Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. Clin Exp Rheumatol 2008; 26: 519-26.
4. BELT NK, KRONHOLM E, KAUPPI MJ: Sleep problems in fibromyalgia and rheumatoid arthritis compared with the general population. Clin Exp Rheumatol 2009; 27: 35-41.
5. WOLFE F, ROSS K, ANDERSON J, RUSSELL IJ, HEBERT L: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 19-28.
6. BAZZICHI L, ROSSI A, MASSIMETTI G et al:. Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol 2007; 25: 225-30.
7. BUSKILA D, NEUMANN L, HAZANOV I, CARMI R: Familial aggregation in the fibromyalgia syndrome. Semin Arthritis Rheum 1996; 26: 1-8.
8. BUSKILA D, NEUMANN L: Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM. J Rheumatol 1997;24:941-44.
9. ROIZENBLATT S, FELDMAN DF, GOLDENBERG J et al.: Juvenile fibromialgia - infantmother association. J Musculoskeletal Pain 1995; 3: 118.
10. Arnold LM, Hudson JI, Hess EV et al.: Family study of fibromyalgia. Arthritis Rheum 2004; 50: 944-52. (Pubitemid 38326195)
11. HUDSON JI, HUDSON MS, PLINER LF, GOLDENBERG DL, POPE HG JR: Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry 1985; 142: 441-6.
12. HUDSON JI, GOLDENBERG DL, POPE HG JR, KECK PE JR, SCHLESINGER L: Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992; 92: 363-7.
13. CHASE TN, MURPHY DL: Serotonin and central nervous system function. Annu Rev Pharmacol 1973; 13: 181-97.
14. RUSSELL IJ, VAEROY H, JAVORS M, NYBERG F: Cerebrospinal fluid biogenic amine metabolites in fibromyalgia / fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992; 35: 550-6.
15. MOLDOFSKY H, WARSH JJ: Plasma tryptophan and musculoskeletal pain in non-articular rheumatism. Pain 1978; 5: 65-71.
16. GODFREY RG: A guide to the understanding and use of Tricyclic Antidepressants in the overall management of Fibromyalgia and other chronic pain syndromes. Archives Int Med 1996; 156: 1047-52.
17. ARNOLD LM, KECK PE JR, WELGE JA: Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 2000; 41: 104-13.
18. KRELL HV, LEUCHTER A, COOK IA, ABRAMS M: Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain. Psychosomatics 2005; 46: 379-84.
19. BERIGAN T, CAN J: The use of atomoxetine adjunctively in fibromyalgia syndrome. Psychiatry 2004; 49: 499-500.
20. CHAUDLER EH, DONG WK: The role of the basal ganglia in nocicepion and pain. Pain 1995; 60: 3-38.
21. MAGNUSSON JE, HSHER K: The involvement of dopamine in nocicepion: the role of D(I) and D(2) receptors in the dorsolateral striatum. Brain Res 2000; 855: 260-6.
22. SCOTT DJ, HEITZEG MM, KOEPPE RA, STOHLER CS.ZUBIETAJK: Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity. J Neurosa 2006; 26: 10789-95.
23. LlN SC, KAPLAN J, BURGER CD, FREDRICKSON PA: Effect of pramipexole in treatment of resistant restless legs syndrome. Mayo Clin Proc 1998; 73: 497-500.
24. Winkelman JW, Sethi KD, Kushida CA et al.: Efficacy and safety of pramipexole in restless legs syndrome. Neurology 2006; 67: 1034-39. (Pubitemid 44454599)
25. HOLMANAJ, MYERS RR: A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum 2005; 52: 2495-505.
26. CLONINGER CR: A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry 1987; 44: 573-88.
27. HEATH AC, CLONINGER CR, MARTIN NG: Testing a model for the genetic structure of personality: a comparison of the personality systems of Cloninger and Eysenck. J Pers Soc Psychol 1994; 66: 762-75.
28. SIGVARDSSON S, BOHMAN M, CLONINGER CR: Structure and stability of childhood personality: prediction of later social adjustment. J Child Psychol Psychiatry 1987; 28: 929-46.
29. COHEN H, BUSKILAD, NEUMANN L, EBSTElN RP: Confirmation of an association between fibromyalgia and the serotonin transporter promoter region (5-HTTLPR) polymorphism and relationship to anxiety-related personality traits. Arthritis Rheum 2002; 46: 845-7.
30. BUSKILA D, COHEN H, NEUMANN L, EBSTEIN RP: An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits. Mol Psychiatry 2004;9:730-1.
31. Wolfe F, Smythe HA, Yunus MB et al.: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990; 33: 160-72.
32. NEUMANN L, BUSKILA D: Quality of life and physical functioning of relatives of fibromyalgia patients. Semin Arthritis Rheum 1997; 26: 834-9.
33. CLONINGER CR, PRZYBECK TR, SVRAKIC DM: The tridimensional personality questionnaire: U.S. normative data. Psychological Reports 1991; 69: 1047-57.
34. MIETTUNEN J, VEIJOLA J, LAURONEN E et al.: Sex differences in Cloninger's temperament dimensions - a meta analysis. Comprehensive Psychiatry 2007; 48: 161-9.
35. EBSTEIN RP, NOVICK O, UMANSKY R et al.: Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nature Genetics 1996; 12: 78-80.
36. BUSKILA D, NEUMANN L: Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM. J Rheumatol 1997; 24: 941-4.
37. PUDD, EISENBERGE, SPRECHER, ROGOWSKI Z, YARNITSKY D: The tridimentional personality theory and pain: harm avoidance and reward dependence traits correlate with pain perception in healthy volunteers. European J Pain 2004; 8: 31-8.
38. ABBATE-DAGA G, FASSINO S, LO GIUDICE R et al.: Anger, depression and personality dimensions in patients with migraine without aura. Psychother Psychosom 2007; 76: 122-8.
39. MALGREN-OLSSON EB, BERGDAHL J: Temperament and character personality dimensions in patients with nonspecific musculoskeletal disorders. Clin J Pain 2006; 22: 625-31.
40. Abrams KY, Yune SK, Kim SJ et al: Trait and state aspects of harm avoidance and its implication for treatment in major depressive disorder, dysthymic disorder, and depressive personality disorder. Psychiatry Clin Neurosci 2004; 58: 240-8. (Pubitemid 38859003)
41. GATCHEL RJ: Psychological disorders and chronic pain: cause-and-effect relationship. In: GATCHEL RJ, TURK DC (Eds.): Psychological approaches to pain management: a practitioner's handbook. New York: Guilford Publications 1996, pp. 33-54.
42. CLAUW DJ, CHROUSOS GP: Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 1997; 4: 134-53.